Pre-clinical study of amcenestrant and HER2-targeted therapies in HER2+/ER+ breast cancer cell line models Breadcrumbs UL Home Research Publications Year of Publication 2023 Journal Cancer Research DOI 10.1158/1538-7445.SABCS22-P3-07-16